735 related articles for article (PubMed ID: 26718746)
1. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
[TBL] [Abstract][Full Text] [Related]
2. Andrographolide sulfonate ameliorates experimental colitis in mice by inhibiting Th1/Th17 response.
Liu W; Guo W; Guo L; Gu Y; Cai P; Xie N; Yang X; Shu Y; Wu X; Sun Y; Xu Q
Int Immunopharmacol; 2014 Jun; 20(2):337-45. PubMed ID: 24704625
[TBL] [Abstract][Full Text] [Related]
3. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide sulfonate ameliorates chronic colitis induced by TNBS in mice via decreasing inflammation and fibrosis.
Gao J; Cui J; Zhong H; Li Y; Liu W; Jiao C; Gao J; Jiang C; Guo W; Xu Q
Int Immunopharmacol; 2020 Jun; 83():106426. PubMed ID: 32220806
[TBL] [Abstract][Full Text] [Related]
5. Elucidation of colon-protective efficacy of diosgenin in experimental TNBS-induced colitis: inhibition of NF-κB/IkB-α and Bax/Caspase-1 signaling pathways.
Tang X; Huang G; Zhang T; Li S
Biosci Biotechnol Biochem; 2020 Sep; 84(9):1903-1912. PubMed ID: 32525764
[TBL] [Abstract][Full Text] [Related]
6. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of trinitrobenzene sulfonic acid-induced colitis in mice by liquiritigenin.
Min JK; Lee CH; Jang SE; Park JW; Lim SJ; Kim DH; Bae H; Kim HJ; Cha JM
J Gastroenterol Hepatol; 2015 May; 30(5):858-65. PubMed ID: 25311527
[TBL] [Abstract][Full Text] [Related]
8. Oridonin's therapeutic effect: suppressing Th1/Th17 simultaneously in a mouse model of Crohn's disease.
Wang S; Zhang Y; Saas P; Wang H; Xu Y; Chen K; Zhong J; Yuan Y; Wang Y; Sun Y
J Gastroenterol Hepatol; 2015 Mar; 30(3):504-12. PubMed ID: 25211373
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
10. Poncirin and its metabolite ponciretin attenuate colitis in mice by inhibiting LPS binding on TLR4 of macrophages and correcting Th17/Treg imbalance.
Kang GD; Kim DH
J Ethnopharmacol; 2016 Aug; 189():175-85. PubMed ID: 27224242
[TBL] [Abstract][Full Text] [Related]
11. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis.
Nakase H; Okazaki K; Tabata Y; Uose S; Ohana M; Uchida K; Nishi T; Debreceni A; Itoh T; Kawanami C; Iwano M; Ikada Y; Chiba T
J Pharmacol Exp Ther; 2001 Jun; 297(3):1122-8. PubMed ID: 11356937
[TBL] [Abstract][Full Text] [Related]
12. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
[TBL] [Abstract][Full Text] [Related]
13. A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
Funakoshi T; Yamashita K; Ichikawa N; Fukai M; Suzuki T; Goto R; Oura T; Kobayashi N; Katsurada T; Ichihara S; Ozaki M; Umezawa K; Todo S
J Crohns Colitis; 2012 Mar; 6(2):215-25. PubMed ID: 22325176
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Du X; Chen W; Wang Y; Chen C; Guo L; Ju R; Li J; Zhang D; Zhu L; Ye C
Int Immunopharmacol; 2017 Apr; 45():16-25. PubMed ID: 28152446
[TBL] [Abstract][Full Text] [Related]
15. Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages.
Jang SE; Jeong JJ; Hyam SR; Han MJ; Kim DH
J Agric Food Chem; 2014 Oct; 62(40):9711-21. PubMed ID: 25213465
[TBL] [Abstract][Full Text] [Related]
16. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation.
Cui L; Feng L; Zhang ZH; Jia XB
Int Immunopharmacol; 2014 Nov; 23(1):294-303. PubMed ID: 25239813
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of thalidomide on trinitrobenzene sulfonate-induced colitis in young rats and its mechanism.
Xu J; Zheng C; Huang Y; Liang Y
Chin Med J (Engl); 2014; 127(12):2368-75. PubMed ID: 24931258
[TBL] [Abstract][Full Text] [Related]
18. Neomangiferin modulates the Th17/Treg balance and ameliorates colitis in mice.
Lim SM; Kang GD; Jeong JJ; Choi HS; Kim DH
Phytomedicine; 2016 Feb; 23(2):131-40. PubMed ID: 26926174
[TBL] [Abstract][Full Text] [Related]
19. Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.
Ukil A; Maity S; Das PK
Br J Pharmacol; 2006 Sep; 149(1):121-31. PubMed ID: 16880762
[TBL] [Abstract][Full Text] [Related]
20. Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis.
Kretzmann NA; Fillmann H; Mauriz JL; Marroni CA; Marroni N; González-Gallego J; Tuñón MJ
Inflamm Bowel Dis; 2008 Nov; 14(11):1504-13. PubMed ID: 18623154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
